newsfilter
← Latest News
GlobeNewswire·

Immuneering to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that